Oct 18, 2023 | AIMS-2-TRIALS News
A groundbreaking shift is needed in the field of autism research to bridge a historical divide between researchers and the autistic community. A recent commentary, co-authored by experts from AIMS-2-TRIALS in collaboration with international institutions and Autism...
Aug 24, 2023 | AIMS-2-TRIALS News
A recent report published by the Innovative Medicines Initiative (IMI), the world’s largest public-private partnership in the life sciences, showed that AIMS-2-TRIALS have published the most papers out of all Phase 2 IMI-funded projects. Since the IMI was launched,...
Aug 2, 2023 | AIMS-2-TRIALS News
The genetics of autism are very complex. Some autistic people have a genetic syndrome associated with autism, like Angelman syndrome or dup15q syndrome, whilst others do not. Given the diversity of autism, it is important that research looks at the broad range of...
Jul 11, 2023 | AIMS-2-TRIALS News
Extensive research shows that far more male individuals are diagnosed as autistic, compared to females. This autism ‘sex-ratio bias’ means that around 4 more males are identified as autistic than females. So why is there a higher diagnosis rate for autism in males?...
May 3, 2023 | AIMS-2-TRIALS News
Sharing scientific research data is important because it can help improve the quality, usefulness, and reliability of research. For example, it enables scientists to analyse larger data sets, which increases their ability to uncover patterns in the data. Data sharing...
